These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin. Sterzik H; Soriano A; Mohamad AM; Martínez JA; Fernandez J; Cobos N; Morata L; Mensa J Scand J Infect Dis; 2011 Oct; 43(10):765-70. PubMed ID: 21696252 [TBL] [Abstract][Full Text] [Related]
25. Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits. Molina KC; Fairman KA; Sclar DA Drug Healthc Patient Saf; 2018; 10():37-43. PubMed ID: 29760569 [TBL] [Abstract][Full Text] [Related]
26. The Association of Serotonin Toxicity with Combination Linezolid-Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis. SanFilippo S; Turgeon J; Michaud V; Nahass RG; Brunetti L Pharmacy (Basel); 2023 Nov; 11(6):. PubMed ID: 37987392 [TBL] [Abstract][Full Text] [Related]
27. Linezolid and fentanyl: An underrecognized drug-to-drug interaction. Corsini Campioli C; Barth D; Esquer Garrigos Z; Abu Saleh O; Sohail RM; Sia IG J Clin Pharm Ther; 2020 Aug; 45(4):825-827. PubMed ID: 32304579 [TBL] [Abstract][Full Text] [Related]
28. Linezolid--a review of the first oxazolidinone. Norrby R Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587 [TBL] [Abstract][Full Text] [Related]
29. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Baldo BA Arch Toxicol; 2018 Aug; 92(8):2457-2473. PubMed ID: 29916050 [TBL] [Abstract][Full Text] [Related]
30. Linezolid: an oxazolidinone antimicrobial agent. Paladino JA Am J Health Syst Pharm; 2002 Dec; 59(24):2413-25. PubMed ID: 12503340 [TBL] [Abstract][Full Text] [Related]
31. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections. Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021 [TBL] [Abstract][Full Text] [Related]
32. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions. Flanagan S; Bartizal K; Minassian SL; Fang E; Prokocimer P Antimicrob Agents Chemother; 2013 Jul; 57(7):3060-6. PubMed ID: 23612197 [TBL] [Abstract][Full Text] [Related]
33. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935 [TBL] [Abstract][Full Text] [Related]
34. Risk of acute kidney injury in critically ill surgical patients with presumed pneumonia is not impacted by choice of methicillin-resistant Billups KB; Reed EE; Phillips GS; Stevenson KB; Steinberg SM; Murphy CV Int J Crit Illn Inj Sci; 2018; 8(1):22-27. PubMed ID: 29619336 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology and Economic Burden of Serotonin Syndrome With Concomitant Use of Serotonergic Agents: A Retrospective Study Utilizing Two Large US Claims Databases. Nguyen CT; Xie L; Alley S; McCarron RM; Baser O; Wang Z Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29286588 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of linezolid in liver transplant patients. Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969 [TBL] [Abstract][Full Text] [Related]
38. A Cross-sectional Analysis of Linezolid in Combination with Methadone or Buprenorphine as a Cause of Serotonin Toxicity. Traver EC; Heil EL; Schmalzle SA Open Forum Infect Dis; 2022 Jul; 9(7):ofac331. PubMed ID: 35899282 [TBL] [Abstract][Full Text] [Related]
39. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. Falagas ME; Vardakas KZ Drug Saf; 2008; 31(9):753-68. PubMed ID: 18707190 [TBL] [Abstract][Full Text] [Related]
40. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial. Li JZ; Willke RJ; Rittenhouse BE; Rybak MJ Surg Infect (Larchmt); 2003; 4(1):57-70. PubMed ID: 12744768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]